TWA
GOSS icon

TCI Wealth Advisors’s Gossamer Bio GOSS Stock Holding History

TCI Wealth Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-397
Closed -$4K – 2306
2021
Q4 		$4K Buy
397
+114
+40% +$1.35K ﹤0.01% 1817
2021
Q3 		$4K Hold
283
– – ﹤0.01% 1744
2021
Q2 		$2K Hold
283
– – ﹤0.01% 2010
2021
Q1 		$3K Buy
+283
New +$2.85K ﹤0.01% 1523

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TCI Wealth Advisors's GOSS Position: Q1 2022 in Review

TCI Wealth Advisors sold out of Gossamer Bio (GOSS) in Q1 2022, closing a stake of 397 shares — an estimated $4K sold.

TCI Wealth Advisors first reported a position in GOSS in Q1 2021 and held it in 4 quarters. The position peaked at $4K in Q4 2021. 141 funds tracked by Wall St. Rank hold GOSS as of Q1 2022.

  • TCI Wealth Advisors reported no remaining Gossamer Bio position as of Q1 2022 after selling out during the quarter.
  • TCI Wealth Advisors sold 397 Gossamer Bio shares in Q1 2022, an estimated $4K.
  • TCI Wealth Advisors first reported a position in Gossamer Bio in Q1 2021 and held it in 4 quarters.
  • TCI Wealth Advisors's Gossamer Bio position peaked at $4K in Q4 2021.
  • 141 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2022.

Based on TCI Wealth Advisors's 13F filing for Q1 2022, filed 29 Apr 2022.